Cenobamate Patent Expiration
Cenobamate is Used for treating partial onset seizures through co-administration with phenobarbital and/or phenytoin. It was first introduced by Sk Life Science Inc
Cenobamate Patents
Given below is the list of patents protecting Cenobamate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xcopri | US11654133 | Use of [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate in combination therapy | Jun 16, 2039 | Sk Life |
| Xcopri | US7598279 | Neurotherapeutic azole compounds | Oct 30, 2032 | Sk Life |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Cenobamate's patents.
Latest Legal Activities on Cenobamate's Patents
Given below is the list recent legal activities going on the following patents of Cenobamate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Electronic Review Critical | 07 Jun, 2024 | US7598279 |
| Mail Pub Notice re 312 amendment | 20 Mar, 2024 | US7598279 |
| Email Notification Critical | 20 Mar, 2024 | US7598279 |
| Post Issue Communication - Certificate of Correction Denied | 15 Mar, 2024 | US7598279 |
| POST ISSUE OTHER COMMUNICATION TO APPLICANT- CERTIFICATE OF CORRECTION | 14 Mar, 2024 | US7598279 |
| Patent Term Extension Certificate Critical | 09 Nov, 2023 | US7598279 |
| Notice of Final Determination -Eligible | 09 Aug, 2023 | US7598279 |
| FDA Final Eligibility Letter Critical | 13 Jul, 2023 | US7598279 |
| Patent Issue Date Used in PTA Calculation Critical | 23 May, 2023 | US11654133 |
| Recordation of Patent eGrant | 23 May, 2023 | US11654133 |
Cenobamate's Family Patents
